Every savvy investor knows the value of uncovering those hidden gems that can potentially yield significant returns. Today, on January 5th, we present three stocks with buy rank and robust momentum characteristics for discerning investors to consider.
Organogenesis Holdings Inc. (ORGO)
Organogenesis has seen its shares surge by 31.8% over the last three months, outpacing the S&P 500’s 8.6% advance. With a Zacks Rank #1 and a Momentum Score of A, the regenerative medicine company has witnessed a 500% increase in the Zacks Consensus Estimate for its current year earnings over the past 60 days.
Cal-Maine Foods, Inc. (CALM)
Cal-Maine has exhibited a remarkable performance as well, with its shares climbing 22.4% during the same period. With a Zacks Rank #1 and a Momentum Score of A, this producer of shell eggs has witnessed a 77.4% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Cloudflare, Inc. (NET)
Cloudflare has also demonstrated its prowess, with a 22.8% surge in its shares over the last three months compared to the S&P 500’s 8.6% advance. With a Zacks Rank #1 and a Momentum Score of B, the cloud services provider has witnessed a 2.2% increase in the Zacks Consensus Estimate for its current year earnings over the past 60 days.
Check out the full list of top-ranked stocks here.
Gain insight into the Momentum score and how it is calculated here.
Excited? Curious? For a mere $1, you can access all Zacks’ buys and sells. No joke. Several years ago, Zacks shocked its members by offering them 30-day access to all picks for only $1. Thousands have seized this golden opportunity, others doubted, and they still wonder — must be a catch. But there’s none. Zacks simply wants you to get familiar with their portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, showcasing 162 positions closed with double- and triple-digit gains in 2023 alone. So, see stocks now and take advantage of this remarkable offer.
For the latest recommendations from Zacks Investment Research, download 7 Best Stocks for the Next 30 Days.
Read this article on Zacks.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
